We speculate that combining these approaches to evaluate alterations in cortical structure as well as peripheral blood cytokines and BDNF in T2DM patients who have not yet exhibited cognitive impairment may give insights into the underlying mechanisms and early detection of T2DM-related cognitive impairment. The gene discussed is BDNF; the disease is type 2 diabetes mellitus.